Dystrophic Epidermolysis Bullosa: Pathogenesis and Clinical Features - 05/08/11
Doi : 10.1016/j.det.2009.10.020
Resumen |
Dystrophic epidermolysis bullosa (DEB) is relatively well understood. Potential therapies are in development. This article describes the pathogenesis and clinical features of DEB. It also describes therapeutic options and the future of molecular therapies.
El texto completo de este artículo está disponible en PDF.Keywords : Blistering, Scarring, Dermal–epidermal junction, Anchoring fibrils
Esquema
| The author’s work on dystrophic epidermolysis bullosa was supported by the EB-Network grant from the Federal Ministry for Education and Research 2003–2011 and by a grant from Debra International. |
© 2010
Elsevier Inc. Reservados todos los derechos.
Vol 28 - N° 1
P. 107-114 - janvier 2010 Regresar al número
Artículo precedente
- Type VII Collagen: The Anchoring Fibril Protein at Fault in Dystrophic Epidermolysis Bullosa
- Hye Jin Chung, Jouni Uitto
- Kindler Syndrome Pathogenesis and Fermitin Family Homologue 1 (Kindlin-1) Function
- Maria-Anna M.A. D’Souza, Roy M. Kimble, James R. McMillan
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?